Literature DB >> 25402387

Precocious presentation of autoimmune polyglandular syndrome type 2 associated with an AIRE mutation.

Eduarda Resende1, Gemma Novoa Gόmez2, Marta Nascimento3, Lourdes Loidi4, Rebeca Saborido Fiaño5, Paloma Cabanas Rodrίguez6, Lidia Castro-Feijoo6, Jesús Barreiro Conde6.   

Abstract

Autoimmune polyglandular syndrome type 2 (type 2 APS), or Schmidt's syndrome, is defined by the presence of Addison's disease in combination with type 1 diabetes and/or autoimmune thyroid disease. The estimated prevalence of this syndrome is 1.4-4.5 per 100,000 inhabitants and it is more frequent in middle-aged females, whilst it is quite rare in children. Type 2 APS, which shows a pattern of autosomal dominant inheritance with low penetrance, has been associated with HLA specific DR3/DQ2 and DR4/DQ8 haplotypes. However, it has been hypothesized that genetic variability in the AIRE gene, which causing type 1 APS, may play a role in more common organ-specific autoimmune conditions like type 1 diabetes, Hashimoto's disease and type 2 APS, among others. Here we present the case of an 8-year-old girl, with a past medical history of type 1 diabetes diagnosed at the age of 3. She was taken to the Emergency Department because she complained of abdominal pain, nausea and vomiting, and her blood analysis revealed a severe hyponatremia. She also had seizures as a consequence of the hyponatremia and frequent hypoglycemia. She was ultimately found to be suffering from autoimmune primary adrenal insufficiency. The combination of both mentioned conditions, type 1 diabetes and Addison's disease, in the absence of chronic mucocutaneous candidiasis, made a diagnosis of type 2 APS plausible in this girl. The genetic study showed two heterozygous variants: NM_000383.2:C.1411C>T (p. Arg471Cys) in exon 12 and IVS9+6G>A in intron 9 of the AIRE gene. The description of an uncommon case of type 2 APS with precocious presentation associated with an AIRE mutation in a very young girl could help to clarify the role of AIRE in the development of autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25402387     DOI: 10.14310/horm.2002.1513

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  2 in total

1.  Autoimmune polyglandular syndrome type 2: A case report.

Authors:  Agyad Bakkour; Mohammed Deeb Zakkor; Lina Taha Khairy; Rostom Horo; Eman Mohammed Sharif Ahmed; Hachem Alhussein
Journal:  Ann Med Surg (Lond)       Date:  2022-05-16

2.  GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility.

Authors:  Daniel Eriksson; Ellen Christine Røyrvik; Maribel Aranda-Guillén; Amund Holte Berger; Nils Landegren; Haydee Artaza; Åsa Hallgren; Marianne Aardal Grytaas; Sara Ström; Eirik Bratland; Ileana Ruxandra Botusan; Bergithe Eikeland Oftedal; Lars Breivik; Marc Vaudel; Øyvind Helgeland; Alberto Falorni; Anders Palmstrøm Jørgensen; Anna-Lena Hulting; Johan Svartberg; Olov Ekwall; Kristian Johan Fougner; Jeanette Wahlberg; Bjørn Gunnar Nedrebø; Per Dahlqvist; Per Morten Knappskog; Anette Susanne Bøe Wolff; Sophie Bensing; Stefan Johansson; Olle Kämpe; Eystein Sverre Husebye
Journal:  Nat Commun       Date:  2021-02-11       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.